$27.69
+0 (+0%)
At Close: Jul 31, 2026
Bavarian Nordic Receives Order to Manufacture Additional Ebola Vaccines
05:17am, Tuesday, 06'th Apr 2021
COPENHAGEN, Denmark, April 6, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has received a new supply order from Janssen Pharmaceutica NV, part of the Janssen P
Bavarian Nordic A/S – Notice Convening Ordinary General Meeting
04:00am, Monday, 29'th Mar 2021
COPENHAGEN, Denmark, March 29, 2021 – Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the annual General Meeting to be held
Bavarian Nordic A/S (BVNKF) CEO Paul Chaplin on Q4 2020 Results - Earnings Call Transcript
02:20pm, Friday, 12'th Mar 2021
Bavarian Nordic A/S (BVNKF) CEO Paul Chaplin on Q4 2020 Results - Earnings Call Transcript
Bavarian Nordic A/S - Articles of Association
04:17am, Friday, 12'th Mar 2021
Updated Articles of Association for Bavarian Nordic A/S.
Bavarian Nordic A/S - Registration of Share Capital Increase of 5,150,000 New Shares Completed
03:58am, Friday, 12'th Mar 2021
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTH
Sign In
Buy BVNKF